Integrated cardiac safety : assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance / J. Rick Turner, Todd A. Durham.
The serious nature of cardiovascular adverse drug reactions occurring in patients makes assessment of a drug's cardiac safety profile a high priority during both development and post-approval monitoring. Integrated Cardiac Safety provides necessary guidance and methodology for professionals ass...
Saved in:
| Online Access: |
Full Text (via ProQuest) |
|---|---|
| Main Author: | |
| Other Authors: | |
| Format: | eBook |
| Language: | English |
| Published: |
Hoboken, N.J. :
John Wiley & Sons,
©2009.
|
| Subjects: |
| Summary: | The serious nature of cardiovascular adverse drug reactions occurring in patients makes assessment of a drug's cardiac safety profile a high priority during both development and post-approval monitoring. Integrated Cardiac Safety provides necessary guidance and methodology for professionals assessing cardiac safety of drugs throughout all stages of the drug's life, from discovery and development through postmarketing research. This self-contained, reader-friendly text is valuable to professionals in the pharmaceutical, biotechnology, and CRO industries, pharmacologists, toxicologists, governm. |
|---|---|
| Physical Description: | 1 online resource (xxviii, 470 pages) : illustrations. |
| Bibliography: | Includes bibliographical references (pages 397-455) and index. |
| ISBN: | 9780470411285 0470411287 0470229640 9780470229644 9780470411292 0470411295 1282002066 9781282002067 |
| Source of Description, Etc. Note: | Print version record. |